Intravenous immunoglobulin (IVIG) therapy in pregnancies complicated by acute Parvovirus B19 infection in the second trimester: a case series
Case Reports in Perinatal Medicine · 29.01.2025 · 14 (1)
DOI: 10.1515/crpm-2025-0010 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Perinatal Medicine, online erschienen am 11.09.2025. Verfasst von Rachel Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maternal Fetal Medicine, Stony Brook University Hospital, Stony Brook, NY, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Intravenous immunoglobulin (IVIG) in pregnancy has been used to treat hematologic conditions, but there is limited literature on its use in acute Parvovirus B19 infection. The purpose of this report is to highlight IVIG treatment recommendations based on low reticulocyte counts and high middle cerebral artery peak systolic velocity (MCA-PSV) values to prevent fetal hydrops, as well as identify which patients would benefit from high-dose IVIG administration in the setting of acute Parvovirus B19 infection in the second trimester. Case presentation We present the treatment of acute Parvovirus B19 infection with IVIG in two affected pregnancies, as an alternative to percutaneous umbilical blood sampling (PUBS) and intrauterine transfusion (IUT).
Conclusions
IVIG may be useful for Parvovirus B19 treatment in patients with erythropoietic suppression, in patients who decline PUBS/IUT with elevated MCA-PSV, and in patients who have difficult access to the placental cord insertion site, unsuccessful attempt at PUBS, or relative contraindications (i.e. significant abdominal surgery, high BMI).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Maternal Fetal Medicine, Stony Brook University Hospital, Stony Brook, NY, USA.
- Department of Obstetrics and Gynecology, Stony Brook University Hospital, Stony Brook, NY, USA.
ORCID-Profile: Rachel Lee, David Garry, Cassandra Heiselman, Tiffany Yang
Zitieren
APA
Lee, R., Garry, D., Herrera, K., Choi, J., Heiselman, C., Bernasko, J., Gonsalves, Z., Stetler, E., Yang, T., Garduno, E., & Avila, C. (2025). Intravenous immunoglobulin (IVIG) therapy in pregnancies complicated by acute Parvovirus B19 infection in the second trimester: a case series. Case Reports in Perinatal Medicine, 14(1). https://doi.org/10.1515/crpm-2025-0010
Vancouver
Lee R, Garry D, Herrera K, Choi J, Heiselman C, Bernasko J, et al. Intravenous immunoglobulin (IVIG) therapy in pregnancies complicated by acute Parvovirus B19 infection in the second trimester: a case series. Case Reports in Perinatal Medicine. 2025;14(1). doi:10.1515/crpm-2025-0010
BibTeX
@article{Lee2025,
author = {Lee, Rachel and Garry, David and Herrera, Kimberly and Choi, Jennifer and Heiselman, Cassandra and Bernasko, James and Gonsalves, Zenobia and Stetler, Emily and Yang, Tiffany and Garduno, Elizabeth and Avila, Cecilia},
title = {Intravenous immunoglobulin (IVIG) therapy in pregnancies complicated by acute Parvovirus B19 infection in the second trimester: a case series},
journal = {Case Reports in Perinatal Medicine},
year = {2025},
volume = {14},
number = {1},
doi = {10.1515/crpm-2025-0010}
}
EUVIMED